Bio-Rad outlines 2026 currency-neutral revenue growth of -3% to +0.5% amid Middle East disruption
Bio-Rad Laboratories, Inc.Class A · LABORATORY ANALYTICAL INSTRUMENTS · Now $305.46
-5.8% in 7d after detection
Post-detection moves
1h
—
1d
+0.5%
3d
+1.0%
7d
-5.8%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS